99 related articles for article (PubMed ID: 4042222)
1. Synthesis and structure-activity study of protease inhibitors. IV. Amidinonaphthols and related acyl derivatives.
Aoyama T; Okutome T; Nakayama T; Yaegashi T; Matsui R; Nunomura S; Kurumi M; Sakurai Y; Fujii S
Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1458-71. PubMed ID: 4042222
[No Abstract] [Full Text] [Related]
2. Synthesis and structure-activity study of protease inhibitors. III. Amidinophenols and their benzoyl esters.
Yaegashi T; Nunomura S; Okutome T; Nakayama T; Kurumi M; Sakurai Y; Aoyama T; Fujii S
Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4466-77. PubMed ID: 6532549
[No Abstract] [Full Text] [Related]
3. Irreversible enzyme inhibitors. CLXV. Proteolytic enzymes. XV. Inhibition of guinea pig complement by derivatives of m-phenoxypropoxybenzamidine.
Baker BR; Cory M
J Med Chem; 1969 Nov; 12(6):1053-6. PubMed ID: 5389147
[No Abstract] [Full Text] [Related]
4. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
Hoffmann A; Markwardt F
Pharmazie; 1989 Feb; 44(2):141-4. PubMed ID: 2748697
[TBL] [Abstract][Full Text] [Related]
5. Aromatic tetra-amidines: synthesis of halo-derivatives and their antiproteolytic activity.
Ferroni R; Menegatti E; Guarneri M; Taddeo U; Bolognesi M; Ascenzi P; Amiconi G
Farmaco Sci; 1984 Nov; 39(11):901-9. PubMed ID: 6569842
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
Hauptmann J; Markwardt F
Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323
[No Abstract] [Full Text] [Related]
7. Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors.
Buckman BO; Chou YL; McCarrick M; Liang A; Lentz D; Mohan R; Morrissey MM; Shaw KJ; Trinh L; Light DR
Bioorg Med Chem Lett; 2005 May; 15(9):2249-52. PubMed ID: 15837303
[TBL] [Abstract][Full Text] [Related]
8. Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. XIV. Inhibition of guinea pig complement by meta-substituted benzamidines.
Baker BR; Cory M
J Med Chem; 1969 Nov; 12(6):1049-52. PubMed ID: 5389146
[No Abstract] [Full Text] [Related]
9. Synthesis and structure-activity study of protease inhibitors. I. (Guanidinophenyl)propionate and guanidinocinnamate derivatives.
Okutome T; Kawamura H; Taira S; Nakayama T; Nunomura S; Kurumi M; Sakurai Y; Aoyama T; Fujii S
Chem Pharm Bull (Tokyo); 1984 May; 32(5):1854-65. PubMed ID: 6467467
[No Abstract] [Full Text] [Related]
10. Synthesis and structure-activity study of protease inhibitors. V. Chemical modification of 6-amidino-2-naphthyl 4-guanidinobenzoate.
Nakayama T; Taira S; Ikeda M; Ashizawa H; Oda M; Arakawa K; Fujii S
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):117-25. PubMed ID: 8448813
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
Aoyama T; Ino Y; Ozeki M; Oda M; Sato T; Koshiyama Y; Suzuki S; Fujita M
Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087
[TBL] [Abstract][Full Text] [Related]
12. Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride.
Baker BR; Cory M
J Med Chem; 1971 Sep; 14(9):805-8. PubMed ID: 5140007
[No Abstract] [Full Text] [Related]
13. Synthesis and study of the anti-leukaemic activity of N,N'-substituted amidines and bis-amidines.
Dumont P; Fuks R; Atassi G; Hanocq M
J Pharm Belg; 1985; 40(6):373-86. PubMed ID: 3831292
[No Abstract] [Full Text] [Related]
14. [Synthesis of antiproteolytically active 3,5-bis(4-amidinobenzyl)- and 3,5-bis(4-amidinobenzylidene)piperidone-(4) derivatives (author's transl)].
Richter P; Wagner G
Pharmazie; 1980 Feb; 35(2):75-7. PubMed ID: 7384187
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of acrosin by benzamidines.
Stürzebecher J
Acta Biol Med Ger; 1981; 40(10-11):1519-22. PubMed ID: 7044006
[TBL] [Abstract][Full Text] [Related]
16. Complement inhibition by amidines and guanidines--in vivo and in vitro results.
Otterness IG; Torchia AJ; Doshan HD
Biochem Pharmacol; 1978; 27(14):1873-8. PubMed ID: 708469
[No Abstract] [Full Text] [Related]
17. [Synthetic inhibitors of serine proteinases. Part 25: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-substituted amidinophenylalanines and 3-amidinophenyl-3-aminopropionic acids (author's transl)].
Stürzebecher J; Horn H; Markwardt F; Wagner G; Walsmann P
Pharmazie; 1981 Sep; 36(9):639-41. PubMed ID: 6458047
[TBL] [Abstract][Full Text] [Related]
18. [Synthetic inhibitors of serine proteinases. Part 21: Studies on the structure-activity relationships in bisamidines (author's transl)].
Walsmann P; Markwardt F; Stürzebecher J; Vieweg H; Wagner G
Pharmazie; 1979 Dec; 34(12):837-9. PubMed ID: 161807
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
Glovsky MM; Cory M; Alenty A
Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
[TBL] [Abstract][Full Text] [Related]
20. [Forssman antigen in cancerous and normal human tissues].
Korosteleva VS; Berdinskikh MS; Kosiakov PN; Pavliuchenkova RP
Vopr Onkol; 1980; 26(2):38-41. PubMed ID: 6987808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
